MBDTA-2 is a novel dual-target herbicidal inhibitor that disrupts plant lysine biosynthesis by targeting two essential enzymes, DHDPS and DHDPR. This innovative approach provides a breakthrough solution for managing herbicide-resistant weeds. By focusing on a biosynthetic pathway unique to plants, it offers a selective, high-potential alternative to traditional agricultural herbicides currently facing declining efficacy.
MBDTA-2 is a novel, dual-target herbicidal inhibitor that disrupts the lysine biosynthesis pathway in plants. By targeting two essential enzymes—dihydrodipicolinate synthase (DHDPS) and dihydrodipicolinate reductase (DHDPR)—this inhibitor offers a promising strategy for managing herbicide-resistant weeds. Because humans and animals do not synthesize lysine and must acquire it through diet, targeting this pathway is highly selective, providing an effective mode of action for next-generation agricultural crop protection.
The inhibitor features a unique mechanism of action:
The technology is currently at TRL 4. Researchers have successfully validated the dual-target mechanism in laboratory settings, demonstrated in vitro enzyme inhibition, and conducted preliminary in planta proof-of-concept studies using model organisms and specific weeds. The technology is supported by international patent filings.
La Trobe University is a comprehensive public research university based in Melbourne, serving metropolitan and regional Australia through a multi‑campus footprint. Its Research and Innovation Precinct at the Bundoora campus enables industry co‑location, shared facilities, and streamlined access to talent. Collaborations with state agencies and Melbourne’s hospital network, plus a digital innovation hub and accelerator programs, provide pathways for prototyping, validation, and co‑development. Research is supported by competitive national funding, including the Australian Research Council and National Health and Medical Research Council, alongside industry partnerships and Cooperative Research Centre programs. A dedicated technology transfer office manages IP, licensing, and startup formation.